These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5828888)

  • 21. MEASLES VACCINATION. IV. RESPONSES TO TWO DIFFERENT TYPES OF PREPARATIONS GIVEN AS A FOURTH DOSE OF VACCINE.
    NORRBY E; LAGERCRANTZ R; GARD S
    Br Med J; 1965 Mar; 1(5438):813-7. PubMed ID: 14258844
    [No Abstract]   [Full Text] [Related]  

  • 22. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
    Unalan H; Ustaçelebi S
    Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined live measles-mumps virus vaccine.
    Weibel RE; Villarejos VM; Hernández G; Stokes J; Buynak EB; Hilleman MR
    Arch Dis Child; 1973 Jul; 48(7):532-6. PubMed ID: 4719108
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison of Edmonston-B and Schwarz measles vaccine in Malian children.
    Jean-Joseph P; Sow S; Casey HL; Imperato PJ; Henderson RH; Noble J
    Lancet; 1969 Mar; 1(7596):665-7. PubMed ID: 4179897
    [No Abstract]   [Full Text] [Related]  

  • 25. Measles (rubeola) susceptibility among elementary schoolchildren.
    Kalis JM; Quie PG; Balfour HH
    Am J Epidemiol; 1975 Jun; 101(6):527-31. PubMed ID: 1155431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on measles in Thailand. IV. Persistence of measles antibody in the absence of natural virus two years after vaccination by the "KL" method.
    Sangkawibha N; Tsuchida P; Bukkavesa S; Ostanonda P; Ueda S
    Biken J; 1971 Jun; 14(2):149-54. PubMed ID: 5122205
    [No Abstract]   [Full Text] [Related]  

  • 27. Durability of antibodies induced by inactivated measles virus vaccine.
    Masuno S; Kaneko T; Arakawa S
    Zentralbl Bakteriol Orig; 1968 Apr; 206(3):353-60. PubMed ID: 5707315
    [No Abstract]   [Full Text] [Related]  

  • 28. Determination of antigenicity of inactivated measles vaccine on guinea pigs.
    Drevo M; Mares I; Závadová H
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(4):389-96. PubMed ID: 5752126
    [No Abstract]   [Full Text] [Related]  

  • 29. HEMAGGLUTINATION-INHIBITION TEST IN THE STUDY OF MEASLES IMMUNITY.
    TOGO Y
    Am J Hyg; 1964 May; 79():250-9. PubMed ID: 14159946
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparative study on antigenicity of live and inactivated measles vaccine.
    Arakawa S; Kaneko T
    Jpn J Exp Med; 1966 Feb; 36(1):37-47. PubMed ID: 5297255
    [No Abstract]   [Full Text] [Related]  

  • 31. [Study on the neutralization capacity of different types of human measles virus vaccine and the epidemic strains].
    Feng Y; Lu YY; Yan JY; Jiang XH; Shi W; Xu CP; Li Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Nov; 28(11):1123-6. PubMed ID: 18396671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of measles hemagglutination inhibiting antibody levels among school children in Ibadan, Nigeria.
    Ogundiji OT; Okonko IO; Adu FD
    J Immunoassay Immunochem; 2013; 34(2):208-17. PubMed ID: 23537304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Notes on the effect of measles and measles vaccine in a virgin-soil population of South American Indians.
    Neel JV; Centerwall WR; Chagnon NA; Casey HL
    Am J Epidemiol; 1970 Apr; 91(4):418-29. PubMed ID: 4192799
    [No Abstract]   [Full Text] [Related]  

  • 34. Development and evaluation of the Moraten measles virus vaccine.
    Hilleman MR; Buynak EB; Weibel RE; Stokes J; Whitman JE; Leagus MB
    JAMA; 1968 Oct; 206(3):587-90. PubMed ID: 5695578
    [No Abstract]   [Full Text] [Related]  

  • 35. Measles vaccination. 3. Serologic responses to immunization with purified hemagglutinin.
    Norrby E; Lagercrantz R; Gard S; Carlström G
    Acta Paediatr Scand; 1965 Nov; 54(6):581-6. PubMed ID: 5832151
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of measles antibody titers measured by the micro- and macro-methods.
    Ueda S
    Biken J; 1971 Jun; 14(2):155-60. PubMed ID: 5122206
    [No Abstract]   [Full Text] [Related]  

  • 37. A study of the protective effect of live measles vaccines 13 to 27 months after vaccination.
    Sejda J; Helcl J; Strauss J; Zdrazílek J; Mírovský J
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(2):187-91. PubMed ID: 5752748
    [No Abstract]   [Full Text] [Related]  

  • 38. Two-year follow-up study of measles vaccine antibodies.
    Med J Aust; 1970 Mar; 1(11):532-4. PubMed ID: 5443510
    [No Abstract]   [Full Text] [Related]  

  • 39. MEASLES-NEUTRALIZING AND HI ANTIBODY TITERS OF HUMAN GAMMA GLOBULIN PREPARATIONS.
    MILLIAN SJ; SCHAEFFER M
    Public Health Rep (1896); 1965 Jan; 80(1):65-7. PubMed ID: 14255454
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunity following congenital measles.
    Dörffel W; Nöbel B
    Scand J Infect Dis; 1972; 4(2):161-3. PubMed ID: 5070510
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.